by Amelia Holmes | Jul 13, 2022 | Blog, Good Distribution Practice - GDP, MHRA, WDA(H)
An Introduced Product is an unlicensed medicine which can be imported from a country other than an approved country for import to be exported to a country other than an approved country for import, or if imported from a non-EEA country into Northern Ireland for export back to a country outside the EEA.
by Chole Greenway | Jul 1, 2022 | Blog, MHRA, WDA(H)
For the distribution of medicines and healthcare products, a licence, authorisation or registration is required depending on the type of activity.
by Steven Hewison | Feb 2, 2022 | Blog, WDA(H)
Drop-shipping; It is not uncommon for WDA(H) licence holders to operate a drop-shipping model where the licence holder instructs supplier(s) to ship directly to their customers on their behalf (without the goods transiting through the licence holder’s premises)....
by Steven Hewison | Dec 16, 2021 | Blog, Consultancy, Export, MHRA, WDA(H), WDA(H)
UK licensed medicinal products and the challenges of exporting – Many clients contact us for information and help on expanding the scope of their WDA license to include the export UK licensed medicinal products without necessarily understanding the challenges of exporting UK licensed medicinal products.
by Steven Hewison | Nov 29, 2021 | Blog, MHRA, WDA(H)
Becoming a Pharmaceutical Wholesale Dealer – Many new clients contact us for information and help on setting up a new business as a Pharmaceutical Wholesale Dealer.
by Sally Finlayson | Jul 14, 2021 | Blog, Export Training, MHRA, WDA(H), WDA(H)
As Great Britain (GB) are no longer part of the European Union (EU) since the 1st of January 2021 exit date. It is essential to ensure all the necessary changes have been made to remain MHRA compliant.